Ligand Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

LGND 55.82 -0.87 (-1.53%)
price chart
Ligand Pharmaceuticals Inc Stock Downgraded (LGND)
LIGAND PHARMACEUTICAL INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Related articles »  
Why Ligand Pharmaceuticals Inc. Shares Popped
What: Shares of Ligand Pharmaceuticals (NASDAQ: LGND ) , a biotechnology company that develops and acquires royalty rights to pharmaceutical products, gained as much as 15% after the company reported better than expected fourth-quarter results and ...
Related articles »  
Share Price of Ligand Pharmaceuticals Inc. Rally 1.67%
Shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) rose by 1.67% in the past week and 2.81% for the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 0.34%.
Ligand Pharmaceuticals Inc. (LGND) Issues Q1 Earnings Guidance
Ligand Pharmaceuticals logo Ligand Pharmaceuticals Inc. (NASDAQ:LGND) updated its first quarter earnings guidance on Monday.
Why Lemelson Capital Is Short On Ligand Pharmaceuticals
Rev. Emmanuel Lemelson is the chief investment officer of Lemelson Capital Management, an investment firm that is short in Ligand Pharmaceuticals Inc. (NASDAQ: LGND). Lemelson recently joined Benzinga's #PreMarket Prep to talk about why he thinks ...
Related articles »  
Ligand Pharmaceuticals Inc. (LGND) Largest Owner Sells Shares
Raising prospects for a continued deterioration in the stock price of Ligand Pharmaceuticals Inc. (NASDAQ:LGND), the largest shareholder in the company has moved to unload shares of the troubled company in a private transactions.
Related articles »  
Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4?
The company said on its third-quarter 2014 call that demand for Captisol increased from new customers as well as several supply contracts supporting large late-stage studies.
Friday Momentum Stocks: Expeditors International of Washington Inc. (EXPD ...  WallStreet Scope
Ligand Pharmaceuticals (LGND) to Release Quarterly Earnings on Monday  The Legacy
Ligand Pharmaceuticals Inc. Insider Trading Update
Ligand Pharmaceuticals Inc. (NASDAQ:LGND),The VP, Corporate Development of Ligand Pharmaceuticals Inc, Desilva Nishan M sold 2,300 shares at $56.34 on February 10, 2015.
Lemeson Ups Ligand Pharmaceuticals Inc. (LGND) Short
Lemelson Capital Management, a private investment management firm, today announced that it has further increased its short position in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) and appended with additional concerns its initial June 16, 2014 research ...
Ligand Pharmaceuticals: Appendix  Seeking Alpha
Related articles »  
Ligand Pharmaceuticals Inc. Registers High Short Interest
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) is in a strong bear grip; the short interest is registered high at 29.23% of the floated shares.